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1. Introduction 
Endometriosis is a common but complex gynecological disorder of unknown pathogenesis. It 
is characterized by ectopic growth of endometrial tissues. Based on Sampson’s classical 
implantation theory, retrograde menstruation, immune escape, adhesion, angiogenesis and 
growth of endometrial cells are essential milestones in the pathogenesis of endometriosis. The 
cellular communications of immune, endothelial and endometriotic cells during endometriosis 
development are mediated via cytokines and chemokines. Many specific cytokines in 
peritoneal fluid of patients with endometriosis are aberrant from normal women. However, 
it’s not clear at which stage of endometriosis these aberrant cytokines begin to change and 
owing to the limitation with human study the functions of these cytokines were only 
investigated in vitro. On the other hand, the onset of angiogenesis is initiated by oxidative 
stress due to cellular and tissue hypoxia, which is mainly coordinated by the hypoxia-
inducible factors (HIFs). HIFs stimulate VEGF transcription and activation in endometriosis 
lesions in acquiring new blood vessels for survival and growth. Monitoring inflammatory 
response, oxidative stress and angiogenesis in the endometriosis lesions is of vital importance 
in understanding the pathophysiological changes during early development of endometriosis. 
In our studies, we investigated for the first time the dynamic changes of oxygen reactive 
species and angiogenesis in the endometriosis implants by in vivo imaging techniques and 
characterized regulation of cytokines, hypoxia and angiogenesis factors within the first 24 hour 
of experimental endometriosis in mice. We identified significant oxidative stress and hypoxia 
responses in the endometriosis implants in early phase only, but specific estrogen-dependent 
cytokine activations and angiogenesis signaling in late phase. In this chapter, we will describe 
the non-invasive in vivo imaging method as a valuable tool for monitoring oxidative stress 
and angiogenesis in endometriosis and to understand its role in the early development and 
growth of endometriosis. We will also demonstrate oxidative stress preceded hypoxia and 
cytokine activation and angiogenesis signaling in the pathogenesis of early endometriosis. 
2. Development of endometriosis 
2.1 Sampson's implantation theory 
Endometriosis is one of most common gynecological disorder, but poorly understood 
condition. As early as in 1860, von Rokitansky (Rokitansky, 1860) is the first one to describe 
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this disease in detail. Since then, several postulated theories explaining the pathogenesis of 
endometriosis were raised. The most popular theory is Sampson’s classical implantation 
theory in 1921 (Sampson, 1921). He proposed that the endometrial fragments of uterine 
endometrium during menstruation can regurgitate through the fallopian tubes and survive 
in the peritoneal cavity, developing to endometriosis.  
There have been numerous studies in human and primate support the implantation 
theory (Bartosik et al., 1986; Halme et al., 1984). However, this hypothesis cannot explain 
why only about 10% women suffer from endometriosis, but the incidence of retrograde 
menstruation should be much higher. What’s more, the endometriotic lesion sometimes is 
present out of peritoneal cavity, such as lungs, brain and heart, instead of peritoneal cavity 
only (Felson et al., 1960; Joseph et al., 1994; Thibodeau et al., 1987). Besides, genetic, 
immunological factors and vascular and lymphatic spread are also essential for 
endometriosis development. Therefore, endometriosis is multifactorial and complicated 
condition. More studies are needed to explicitly understand the pathogenesis of 
endometriosis. 
2.2 Pathophysiology 
With numerous clinical and basic researches on endometriosis, especially peritoneal 
endometriosis, based on Sampson’s retrograde menstruation theory, it’s well accepted that 
the appearance of vital endometrial cells is the first step. Then immune escape, adhesion, 
implantation, angiogenesis and proliferation are all very important during the development 
of endometriosis (Fig. 1).  
 
Fig. 1. Summary of the development of endometriosis 
In healthy women, macrophages, lymphocytes, natural killer cells and leukocytes eliminate 
ectopic endometrial cells (Braun et al., 1996). Though the number of immune cells in 
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peritoneal fluid of women with endometriosis was significantly higher than women without 
this disease, the function of increased immune cells was decreased (Berkkanoglu et al., 2003). 
Meanwhile, these defected immune cells may secrete some cytokines and growth factors, 
such as interleukin-1 (IL-1), interleukin-8 (IL-8), monocyte chemotactic protein 1 (MCP-1) 
and vascular endothelial growth factor (VEGF) etc., which may help the endometrial cells 
escape from immune surveillance to adhere to the peritoneum, establish microvessels and 
finally grow under the stimulation of estrogen cycle (Kyama et al., 2003). However, the 
reasons causing impaired immune cells are not known. When and what kind of cells as well 
as molecules taking part in the process from survival to steady growth are still not clear.   
2.3 Cellular communications 
Endometrial cells have to contact with immune cells, peritoneal lining and vascular 
endothelial before final growth and maintenance in ectopic location. Cellular immune 
response is responsible for implantation of the retrograde and vital endometrial cells. The 
molecules secreted by immune cells would effect the reaction between endometrial cells and 
other cells.  
2.3.1 Macrophages  
Macrophages are the most abundant immune cells in peritoneal fluid and their main role is 
to phagocytose cellular debris and pathogens. They can also promote lymphocytes and 
other immune cells to respond to pathogens (Tariverdian et al., 2009; van Furth et al., 1979). 
It has been reported that the number and activity of macrophages in peritoneal fluid 
significantly increased. However they cannot clear the ectopic endometrial cells and inhibit 
the development of endometriosis. Modulators of activated macrophages for both immune 
and non-immune cells promote growth and maintenance of ectopic lesion (Lebovic et al., 
2001). There are several evidence to support the change of receptors expression on 
macrophages leads to impaired scavenger function, which might be caused by abnormal 
cytokines and growth factors in the peritoneal fluid of women with endometriosis 
(Berkkanoglu et al., 2003).  
2.3.2 Lymphocytes 
The two main types of lymphocytes are: B cells accounting for humoral acquired response 
by secreting soluble antibodies into the body’s fluids for eliminating foreign antigens, and T 
cells responsible for cellular responses. Both of which recognize specific antigen targets. T 
cells are mainly differentiated into helper T cells promoting antibody production secreted by 
B cells, regulatory T cells controlling immune response, and cytotoxic/suppressor T cells 
killing infected cells and cancer cells in the thymus. In endometriosis, it was reported that 
the proliferation and cytotoxic activity of lymphocytes in peripheral blood is decreased 
(Dmowski et al., 1981; Steele et al., 1984). Increased T cells, both helper and suppressor T 
cells, in peritoneal fluid and ectopic endometriotic tissue was observed in women with 
endometriosis (Dmowski et al., 1994; Hill et al., 1988; Mettler et al., 1996). However, the 
changes are not consistent. Besides, the function and activity of peripheral T cells might be 
different from those in peritoneal fluid. In all, it’s controversial if the alteration of 
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2.3.3 Natural killer cells 
Natural killer cells (NK cells) constitute a major component of the innate immune system. 
They have two ways to take part in host defense by expressing different receptors binding to 
target cells. One receptor type binds immunoglobulin G (IgG). The other includes killer-
activating receptors promoting cytotoxic activity and killer-inhibitory receptors (KIR) 
suppressing cytotoxic activity (Moretta et al., 1995). Oosterlynck and Wilson have found that 
the cytotoxic activity of peripheral and peritoneal fluid NK cells from women with 
endometriosis was obviously decreased with the severity of endometriosis (Oosterlynck et 
al., 1991; Wilson et al., 1994). The decreased NK-mediated cytotoxicity in the peritoneal fluid 
might contribute to the establishment of endometriosis. The mechanisms that cause aberrant 
NK cell cytotoxicity are unclear, but seem to be involved in KIR expression (Wu et al., 2000). 
In a recent study, Maeda et al. reported KIR2DL1 as the subclass of KIR overexpressed on 
NK cells in peripheral and peritoneal fluid of patients with endometriosis.  
2.3.4 Peritoneal cells 
Several adhesion moleculars were found to be expressed in endometrium, which mediate 
the adhesion and invasion of endometrial cells to peritoneum. Koks found that 
endometrium preferentially adhere to the extracellular matrix (ECM) of the peritoneum 
mediated by integrin (Koks et al., 2000). Endometrium expresses various integrins during 
menstruation shedding and the adhesion can be disrupted by blocking integrin. Integrins 
are cell-surface glycoproteins acting as receptors for ECM proteins. In normal eutopic 
endometrium, integrins are important in the interaction between glandular epithelial and 
stromal cells, and essential for implantation (Lessey et al., 1992). After adherence of 
endometrial cells to the peritoneum, local degradation of the ECM is required for invasion 
and implantation. Metalloproteinases (MMPs) causing ECM breakdown, tissue collapse and 
menstruation was up-regulated in late secretory phase (Salamonsen et al., 1996). This implies 
that the vital endometrial cells in peritoneal cavity during menstruation shedding already 
have the potential to invade into peritoneum. What’s more, MMPs are present independent 
of the cycle phase in peritoneal and ovarian endometriosis (Salamonsen et al., 1996), which 
promotes endometriotic cells to infiltrate into peritoneum further although endometriosis 
has been established.   
2.3.5 Vascular endothelial cells 
The ectopic endometrial cells require an accessible blood supply to proliferate and invade 
through the peritoneum after escaping immune surveillance. Greater angiogenic activity have 
been found in the peritoneal fluid of women with endometriosis, which are modulated by 
growth factors and cytokines such as VEGF & IL-8 secreted by ectopic endometrial cells and 
defected immune cells (Oosterlynck et al., 1993). VEGF is a mitogen for endothelial cells and 
stimulates the proliferation of both vascular and lymphatic endothelial cells in vitro (Joukov et 
al., 1997) and promotes angiogenesis or hyperplasia of lymphatic vessels in vivo (Jeltsch et al., 
1997). Increasing evidence indicate that VEGF plays an important role in the angiogenesis of 
peritoneal endometriosis (McLaren, 2000). VEGF is elevated in the peritoneal fluid and 
endometriotic lesion of women with endometriosis and correlated with the severity of this 
disease (McLaren et al., 1996). Its expression is more pronounced around red endometriotic 
lesions as compared with the more inactive black implants (Donnez et al., 1998). 
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2.4 Molecular modulations 
Cellular communications in endometriosis mediated by inflammatory cytokines and growth 
factors is mainly regulated by nuclear factor-κB (NF-κB) signaling pathway (Fig. 2) 
(Gonzalez-Ramos et al.). NF-κB mediated gene transcription promoting inflammation, 
invasion, angiogenesis, and cell proliferation and inhibiting apoptosis of endometriotic cells 
through p50/p65 dimers and NF-κB inhibitor IκBǂ has been found in vitro and in vivo 
studies (Gonzalez-Ramos et al., 2010). Constitutive activation of NF-κB has been 
demonstrated in endometriotic lesions and peritoneal macrophages of patients with 
endometriosis (Laird et al., 2000). Some drugs such as GnRH blocking NF-κB have been 
proven efficient at reducing endometriosis-associated symptoms in women (Han et al., 
2003). Overload iron produced by erythrocytes from menstruation shedding and cytokines 
such as interleukin-1 (IL-1) and tumor necrosis factor-ǂ (TNF-ǂ) as well as oxidative stress 
stimulate NF-κB activation in macrophages and ectopic endometrial cells, which stimulates 
synthesis of proinflammatory cytokines, sending a positive feedback loop to the NF-κB 
signaling pathway. NF-κB activation enhances factors of anti-apoptosis, growth, invasion 
and angiogenesis as well as proinflammatory cytokines such as cyclooxygenase 2 (COX-2), 
vascular endothelial growth factor (VEGF), macrophage migration inhibitory factor (MIF), 
interleukin-1 (IL-1) and tumor necrosis factor-ǂ (TNF-ǂ), which promote the development of 
endometriosis. Intercellular adhesion molecule-1 (ICAM-1) and RANTES up-regulated by 
NF-κB activity could attract more macrophages to sites of inflammation.   
 
Fig. 2. NF-κB signaling pathway in endometriosis 
3. Early pathogenesis 
3.1 Oxidative stress 
Oxidative stress has been proposed as a potential factor in the pathogenesis of endometriosis 
(Van Langendonckt et al., 2002). Oxidative stress may occur when the balance of reactive 
oxygen species (ROS) and antioxidant is disturbed. Several studies have demonstrated that the 
oxidative stress is involved in endometriosis with increased concentration of ROS, enzymes 
producing ROS and lower concentration of antioxidant in peritoneal fluid and in the eutopic 
and ectopic endometrium of women with endometriosis (Ota et al., 2001; Zeller et al., 1987). It’s 
postulated that oxidative stress is stimulated by erythrocytes (Brosens, 1994), apoptotic 
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endometrial tissue, cell debris and macrophages (Murphy et al., 1998). These inducers may 
cause activation and recruitment of mononuclear phagocytes which induce oxidative stress. 
Oxidative stress might lead to a localized pelvic inflammatory reaction with increased pro-
inflammatory mediators, cytokines and growth factors (Gupta et al., 2006). These cytokines 
and growth factors have been widely accepted to promote the immune modulation, adhesion, 
invasion and angiogenesis of endometriosis. Therefore, understanding of oxidative stress 
could give a light in the initiation and process of angiogenesis and inflammation during the 
development of endometriosis. However, two other studies could not find the imbalance 
between ROS and antioxidant in the peritoneal fluid of women with endometriosis (Ho et al., 
1997; Wang et al., 1997). This discrepancy might be due to the use of markers of oxidative 
stress. Thus, further studies are needed to identify when and how oxidative stress play a role 
in the pathophysiology of endometriosis in particular during early development. 
3.2 Proinflammatory responses 
It’s widely accepted that endometriosis is a pelvic inflammatory process with defected 
function of immune system and increased level of abnormal cytokines, chemokines and 
growth factors in the peritoneal fluid modulating the growth and inflammation of 
endometriosis. The proinflammatory cytokines and chemokines involved in development of 
endometriosis include IL-1, IL-6, IL-8, MCP-1 and RANTES (Table 1). These cytokines are 
mostly secreted by activated immune cells and endometrial cells. They act as paracrine and 
autocrine messengers in cellular communication. On the one hand, some of these cytokines 
mediate the adhesion of endometrial cells to peritoneum, such as ICAM-1 and TNF-ǂ and 
promote proliferation of endometrial cells, such as IL8, as well as stimulate angiogenesis 
such as VEGF. On the other hand, some cytokines modulate immune cells function: 
transforming growth factor beta (TGF-ǃ) inhibiting T and B lymphocytes and NK cells 
which may cause immune tolerance; MCP-1 activating macrophages. The imbalance and 
abnormal distribution of peritoneal fluid cytokines and their functions imply that 
inflammation plays a key role in the development of endometriosis. 
Whether pelvic inflammation cause endometriosis or endometriosis results in pelvic 
inflammation is still not well defined. Due to the unsatisfactory diagnostic methods and the 
limitation of human researches, we are not able to answer this question in human because 
most patients have had endometriosis for an unknown disease course at the time of 
diagnosis. Studying endometriosis using animal models complement the understanding 
endometriosis in human. Chen et al. have found that the endometrial cells in the peritoneal 
fluid induced the production of IL-1ǃ, TNF-ǂ, VEGF and MCP-1 at 24 hours in the 
peritoneal fluid of mice. (Chen et al.). Similarly, IL-2, IL-4, IL-6, IL-10 and MCP-1, eosinophil 
chemotactic protein (eotaxin), macrophage inflammatory protein and RANTES as well as 
CC chemokine receptor (CCR1) were found remarkably expressed in endometriotic lesions 
on the 4th day in rat model by autologous transplantation of endometrial epithelial fragment 
to peritoneum (Umezawa et al., 2008). These inflammation cytokines found in early 
endometriosis is consistent with those found in peritoneal fluid of women with 
endometriosis. Based on this finding, it can be supposed that endometrial cells in peritoneal 
cavity might cause inflammation mediating and promoting the development of 








IL-1           Activates T-lymphocytes                               (Vigano et al., 1998) 
Differentiates B cells                           (Lebovic et al., 2000) 
Increase IL-6, sICAM-1, IL-8 & VEGF                    (Arici et al., 1993) 
IL-6          Stimulate B cell activity                            (Le et al., 1989) 
Differentiate T cells                                  (Giudice, 1994) 
Stimulate angiogenesis (Lin et al., 2006) 
IL-8          Promote proliferation of endometrial     and 
endometriotic stromal cells               
(Iwabe et al., 1998) 
Stimulate adhesion of endometrial cells to 
fibronectin                           
(Arici et al., 1998) 
Recruit neutrophils and lymphocytes (Garcia-Velasco et al., 
1999)
MCP-1         Activate macrophages                   (Oral et al., 1996) 
Stimulate endometrial cell proliferation     (Arici et al., 1997) 
RANTES Attract macrophages and lymphcytes       (Khorram et al., 1993) 
ICAM-1     Mediate cell adhesion                   (Oral et al., 1996) 
Inhibit NK cells cytotoxicity               (Koninckx et al., 1998) 
TGF-ǃ     Attract monocytes (Oosterlynck et al., 1994) 
Inhibit T and B lymphocytes and NK cell activity    
TNF-ǂ          Initiate the cascade of cytokines and 
inflammatory response        
(Laird et al., 1996) 
Increase the adherence of cultured                    
endometrial stromal cells
(Zhang et al., 1993) 
VEGF          Stimulate angiogenesis; Attract monocytes               (McLaren et al., 1996) 
Table 1. Functions of cytokines and growth factors involved in endometriosis 
3.3 Angiogenesis 
The establishment of new blood vessels is essential in growth and survival of endometriosis. 
Increased angiogenic activity has been demonstrated in peritoneal fluid of women with 
endometriosis and strong expression of angiogenic factors has been shown in active lesions 
(Donnez et al., 1998; Nisolle et al., 1993). Moreover, inhibition of endometrial implants by 
anti-angiogenic agents or VEGF receptors (VEGFR) blocker was observed in animal studies 
(Dabrosin et al., 2002; Nap et al., 2004). Many anti-angiogenic compounds are studied 
extensively in animal models of endometriosis. Vlahos stated that pentoxifylline used in the 
treatment of peripheral vascular disease for many years may cause suppression of 
endometriotic tissue by inhibiting angiogenesis through VEGF-C and VEGFR-2 expression 
in rat model (Vlahos et al.). Besides, progestins already used in the treatment of 
endometriosis inhibit human ectopic endometrial lesions in a mouse model by regulating 
cysteine-rich angiogenic inducer (CYR61), basic fibroblast growth factor (bFGF) and VEGFA 
(Monckedieck et al., 2009). Endostain, a potent endogenous inhibitor of blood vessel growth, 
suppress angiogenesis by inhibiting endothelial migration without effecting normal estrous 
cycles (Becker et al., 2006). What’s more, either selective cyclooxygenase-2 (COX-2) inhibitor 
or immunoconjugate molecule (Icon) suppress angiogenesis in animal models by 
microvessels density assessment (Krikun et al.). However, there is no study to investigate 
the early process of angiogenesis in endometriosis, which makes new anti-angiogenesis 
therapy possible for prevention of reoccurrence after surgical treatment.    
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4. Experimental designs 
Oxidative stress, proinflammatory responses and angiogenesis of endometriosis are 
important during early development of endometriosis. We postulate that the refluxed 
endometrial tissues in peritoneal cavity could stimulate oxidative stress and 
proinflammatory cytokines which promote the endometriotic adhesion, angiogenesis and 
implantation (Fig. 3). The methods we used are complementary to each other’s insufficiency 
(Table 2).  
 
Fig. 3. Summary of early pathogenesis in endometriosis 
 Method   Advantage Disadvantage 
Oxidative 
stress          
IVIS in vivo, longitudinal, semi-
quantitative        
Expensive 
 ROS or RNS 
markers    
in vitro, quantitative, sensitive         non-longitudinal, not 
stable                              
Angiogenesis Cellvizio, IVIS     in vivo, longitudinal, semi-




markers       
in vitro, quantitative                    non-longitudinal 
Cytokines Antibody Array small sample, all cytokines, semi-
quantitative    
expensive, non-
longitudinal 
 Multiplex small sample, selected cytokines, 
quantitative              
expensive, non-
longitudinal 
 ELISA large sample, specific cytokines, 
quantitative, sensitive               
non-longitudinal          
Table 2. Comparison of available study methods 
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4.1 Oxidative stress in early endometriosis  
In order to monitor the oxidative stress response in early development of endometriosis, an 
experimental endometriosis model in C57 mice was established by subcutaneous injection of 
mouse endometrium fragments. A chemiluminescent probe, L-012 (25mg/kg s.c.), was 
injected to the mice for the noninvasive in vivo oxidative stress imaging. L-012 is a new 
luminol derivative and sensitive chemiluminescence probe reacting with various types of 
ROS. ROS and reactive nitrogen species (RNS) production in the transplanted lesion can be 
monitored longitudinally by Xenogen IVIS 200 Imaging System. The results showed that In 
vivo imaging demonstrated significant increased bioluminescence signals for ROS/RNS 
from the transplanted lesions at the first hour interval. The signal reached a peak after 4 
hours of transplantation. Then, the signal gradually decreased and maintained at minimal 
intensity in the rest of experiment. Immunohistochemistry showed positive lag correlation 
for the stained Hypoxia-inducible factors (HIF-1) in glandular epithelial cells and stromal 
tissue from the isolated lesions across the later time after transplantation. For angiogenesis, 
CD34, VEGF and Von Willebrand factor (vWF) signals were increased in parallel with HIF 
expression at 1 week thereafter. The non-invasive in vivo imaging method provides a 
valuable tool for monitoring oxidative stress in endometriosis and to understand its role in 
the early development and growth of endometriosis. The study indicated oxidative stress 
preceded HIF activation and VEGF angiogenesis in the pathogenesis of early endometriosis. 
4.2 Cytokine profiling in early endometriosis  
Both donor and recipient BALB/c mice at 7 weeks old were subjected to ovariectomy (OVX) 
and then were supplemented with 100ug/kg estradiol. Uterine horns from the donor mice 
were removed into F12 medium. Endometrium was punched into endometrial fragments 
after peeling off the serosa and myometrium under microscope. Fragments suspended in 
0.3ml PBS were injected into peritoneal cavity of recipient mice. Peritoneal fluid was 
collected at experiment time intervals after transplantation. Cytokines profiles in peritoneal 
fluid were detected simultaneously. Differentially expressed cytokines were confirmed by 
ELISA quantification. 
The results showed that the levels of CD30, CD36/SR-B3, Dickkopf-related protein (Dkk-1), 
epidermal growth factor (EGF), Eotaxin, IL-1 receptor antagonist (IL-1ra), IL-6 and Vascular 
cell adhesion protein 1 (VCAM-1) were significantly increased with the first hour of 
transplantation. This is the first report to analyze the peritoneal fluid cytokines profiles in 
experimental endometriosis in mice. The change pattern of cytokines could provide insights 
in understanding the early development of endometriosis. From the results, we can see that 
the oxidative stress and abnormal cytokine profiles might contribute to the early 
development of endometriosis.  
4.3 Angiogenesis in early endometriosis 
Mice were randomly treated with epigallocatchin-3-gallate (EGCG) extracted from green 
tea, Vitamin E (antioxidant controls) or vehicle (negative controls) for in vivo and in vitro 
microvessel imaging at the end of intervention. Microvascular networks in the 
endometriotic lesions in vivo were imaged by Cellvizio LAB LSU-488 with ProFlex 
Microprobe S1500. Microvessel length and area were measured using Cellvizio LAB Vessel 
Detection software and averaged from 4 perpendicular regions of the lesion in replicate. 
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Endometriotic implants were collected for angiogenesis microarray and pathway analysis 
after microvessel assessments in vivo. Differentially expressed angiogenesis molecules CD34, 
VEGFA, VEGFB, VEGFC, VEGFD, VEGFR1, VEGFR2 and VEGFR3 were confirmed by 
quantitative PCR, Western blot and immunhistochemistry. Effects of EGCG on angiogenesis 
signal transduction were further characterised in human endothelial cell line. Microvessel 
parameters and angiogenesis VEGFC/VEGFR2 signaling pathway including Jun proto-
oncogene (cJUN), interferon-gamma (IFNG), matrix metallopeptidase-9 (MMP9) and 
chemokine (C-X-C motif) ligand-3 (CXCL3) in endometriotic implants and endothelial cells 
were studied. The results showed that EGCG, but not Vitamin E, inhibited microvessels in 
endometriotic implants. EGCG selectively suppressed VEGFC and tyrosine kinase receptor 
VEGFR2 expression. EGCG down regulated VEGFC/VEGFR2 signaling through cJUN, 
IFNG and MMP9/CXCL3 pathways for endothelial proliferation, inflammatory response 
and mobility. EGCG also suppressed VEGFC expression and reduced VEGFR2 and 
extracellular signal-regulated kinases (ERK) activation in endothelial cells. VEGFC 
supplementation attenuated the inhibitory effects by EGCG.  
5. Prospective and proposal 
5.1 Clinical significance and potential applications 
Up to date, the only way to diagnose endometriosis is laparoscopy which is minimal 
invasive but expensive. Non-invasive and cheap diagnostic methods are urgent to be 
developed. CA-125 is a widely used serum marker for the diagnosis and evaluation of 
recurrent endometriosis or the success of a surgical treatment. A recent meta-analysis 
including twenty three studies and assessing the diagnostic performance of serum CA125 
has shown that it’s a poor diagnostic method with 90% specificity and 28% sensitivity (Mol 
et al., 1998). One study has found serum IL-6 and peritoneal fluid TNF-ǂ were able to 
discriminate between patients with and without endometriosis (Bedaiwy et al., 2002). They 
stated the sensitivity and specificity of serum IL-6 reached 80% and 87% respectively, which 
is significantly higher than that of CA-125. It indicates that no inflammatory cytokine make 
a potential biomarker for diagnosis of endometriosis. Its predictive values in early 
endometriosis require further investigation. 
In addition, the recognition of pathogenesis is able to provide new concept to the current 
unsatisfactory treatments. Hormone medicine is a commonly used drug for prevention of 
occurrence after surgical treatment. However, lots of patients are not sensitive to these 
medicines or cannot endure the side effects, such as vomiting and weight gain. New therapy 
with less adverse effects and more effective function needs to be developed. The study of 
oxidative stress, inflammation and angiogenesis in the pathogenesis of early endometriosis 
make it possible. For example, antioxidant therapy with 1200 IU of vitamin E and 1 g of 
vitamin C for a period of two months lead to a decrease in the inflammation cytokines such 
as MCP-1, RANTES and IL-6 in peritoneal fluid (Nalini Santanam, 2003). Another drug 
mifepristone with antioxidant effects was also found to exert an inhibitory effect on 
endometrial cell growth (Guo et al.). As angiogenesis, the VEGF inhibitor and anti-VEGF 
antibody have been demonstrated to be effective to control and inhibit implant lesion in 
mice model (Hull et al., 2003). As process of endometriosis contains several steps, the ideal 
medicine has the potential to control the development of progression of endometrium in 
early pathophysiological stage (Fig. 4). 
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Fig. 4. Hypotheses and clinical potentials of endometriosis 
5.2 Study limitations  
Due to unavailable systematic studies, the understanding about this disease is still limited 
although endometriosis has been studied for many years. The limitations and difficulties are 
as below: 
First, at the time of diagnosis endometriosis has already been established with unknown 
history. Hence, it’s impossible to undertake clinical research from the onset to maintenance, 
which mainly makes the etiology still unknown. Second, it’s difficult to have adequate 
control group. The control women involved in most studies are patients without 
endometriosis, which means they might have other disease, such as uterine myoma and 
benign ovarian tumor. The difference between normal eutopic and ectopic endometrium as 
well as normal pelvic environment and that with endometriosis is impossible to study in 
human. Third, we have already known genetic, immune system and peritoneal 
microenviroment are associated with endometriosis, which is supported by different 
curative effect with the same treatment for different patients and diverse symptoms. 
Therefore, the clinical treatment is individual and personal which increase the difficulty to 
observe and compare the different treatments. Fourth, only human and primates suffer from 
spontaneous endometriosis. The reproductive anatomy, physiology and estrogen cycle 
characteristics of monkeys are similar to human. Therefore, monkeys are the best animal 
model to do studies which can not carry out in humans. However, only few centers have the 
capacity to maintain this expensive animal. The most commonly used animal model is 
rodents, but there is an enormous phylogenetic gap between these animals and human. 
Hence, the question is how much data from these rodent models can be extrapolated to 
human situation. Fifth, primary endometrial and endometriotic epithelial cells cannot be 
passaged and fall into senescence within 2 weeks, but a stable cell line is necessary for the 
mechanism study. Until now, there are no stable and commercial normal endometrial and 
endometriotic glandular and stromal cells available for studying. Several researchers 
immortalized these cells by using human telomerase reverse transcriptase (hTERT) (Kyo et 
al., 2003) or transfecting SV40 T-antigen vector (Zeitvogel et al., 2001). However, how much 
characteristics these immortalized cells are similar to primary endometrial cells are needed 
to approve.  
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Endometriosis is a multifactorial disorder including retrograde menstruation, immune 
tolerance, adhesion, transplantation and proliferation modulated by abnormal inflammatory 
cytokines profile in peritoneal fluid. Future studies are necessary to focus on the whole 
picture of signaling pathway in early pathogenesis.  
The current treatments mainly focus on inhibiting estrogen and its receptors which are not 
useful for every patient with endometriosis because estrogen is only one factor in the 
development of endometriosis. The signaling pathway is essential and makes it possible to 
develop an effective medication which could not only decrease estrogen level but also 
inhibit inflammation cytokines, ROS and angiogenesis. On the other hand, complete 
understanding of pathogenesis of endometriosis such as cytokines could provide a new way 
to diagnose and even to divide the disease into different stages according to 
pathophysiolocal characteristics, which makes the treatment individual and personal.  
What’s more, prevention of endometriosis after surgery is also very important. The current 
medicines used for prevention of recurrence are not very effective and have various side 
effects. The understanding of pathogenesis of early endometriosis may produce a better 
therapy to prevent recurrence. Ultimately, more clinical and basic researches should be 
carried out to overcome the complicated disease. 
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